EWA
DARE icon

EverSource Wealth Advisors’s Dare Bioscience DARE Stock Holding History

EverSource Wealth Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42
Closed -$100 – 4356
2025
Q2 		$100 Hold
42
– – ﹤0.01% 4132
2025
Q1 		$121 Hold
42
– – ﹤0.01% 3791
2024
Q4 		$131 Hold
42
– – ﹤0.01% 3510
2024
Q3 		$136 Buy
+42
New +$144 ﹤0.01% 2973

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EverSource Wealth Advisors's DARE Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Dare Bioscience (DARE) in Q3 2025, closing a stake of 42 shares — an estimated $100 sold.

EverSource Wealth Advisors first reported a position in DARE in Q3 2024 and held it in 4 quarters. The position peaked at $136 in Q3 2024. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining Dare Bioscience position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 42 Dare Bioscience shares in Q3 2025, an estimated $100.
  • EverSource Wealth Advisors first reported a position in Dare Bioscience in Q3 2024 and held it in 4 quarters.
  • EverSource Wealth Advisors's Dare Bioscience position peaked at $136 in Q3 2024.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.